Pathology and Biorepository Core (Core B)

病理学和生物样本库核心(核心 B)

基本信息

  • 批准号:
    10246329
  • 负责人:
  • 金额:
    $ 13.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

SUMMARY: PATHOLOGY AND BIOREPOSITORY CORE (CORE B) A fundamental component of the translational research of the MD Anderson Cancer Center Brain Cancer SPORE is conduct of focused translational research involving human tissue and blood specimens, allowing investigation of the biology of target and normal tissues, and evaluation of treatment effects on both target and normal tissue and on modulation of specific, relevant biomarkers. The Pathology and Biorepository Core collects, processes and maintains human tissue specimens from patients and will disperse these tissues and tissue-derived primary glioma stem cell (GSC) to SPORE investigators. It has been an effective resource for the existing SPORE projects, which are heavily tissue-dependent and will continue to serve this function in the proposed SPORE Projects going forward. The specific aims of the Pathology and Biorepository Core are these: Aim 1: Tissue banking. Maintain and enhance the existing repository of glioma tissue, glioma stem cell (GSC) lines, and patient-matched blood specimens, derived from MDACC patients. Aim 2: Resource distribution. Provide glioma tissue, GSCs, and matched blood to SPORE investigators to facilitate basic, translational, and preclinical investigations. Aim 3: Pathology expertise and essential services. Provide comprehensive support for the histopathological, immunohistochemical, and molecular characterization of human tissue specimens as well as samples generated from animal models through the course of SPORE investigations. Aim 4: Integrated data basing. Support a comprehensive, integrated database linking detailed clinical, pathological, and radiographic data with patient-derived tissue resources in the biorepository. Aim 5: Inter-SPORE collaboration. Facilitate inter-SPORE collaborations through sharing of tissue resources.
总结:病理学和生物库核心(核心b)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason Huse其他文献

Jason Huse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason Huse', 18)}}的其他基金

Characterizing heterochromatin dysfunction as a driving alteration in cancer
将异染色质功能障碍描述为癌症的驱动改变
  • 批准号:
    10214571
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Characterizing heterochromatin dysfunction as a driving alteration in cancer
将异染色质功能障碍描述为癌症的驱动改变
  • 批准号:
    10653138
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Characterizing heterochromatin dysfunction as a driving alteration in cancer
将异染色质功能障碍描述为癌症的驱动改变
  • 批准号:
    9796959
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Characterizing heterochromatin dysfunction as a driving alteration in cancer
将异染色质功能障碍描述为癌症的驱动改变
  • 批准号:
    10455442
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Pathology Core
病理学核心
  • 批准号:
    8555356
  • 财政年份:
    2011
  • 资助金额:
    $ 13.32万
  • 项目类别:
Pathology and Biorepository Core (Core B)
病理学和生物样本库核心(核心 B)
  • 批准号:
    10005135
  • 财政年份:
    2008
  • 资助金额:
    $ 13.32万
  • 项目类别:
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
解读黑人和西班牙裔少数群体胶质瘤的种系和体细胞基因组景观
  • 批准号:
    10005140
  • 财政年份:
    2008
  • 资助金额:
    $ 13.32万
  • 项目类别:
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
解读黑人和西班牙裔少数群体胶质瘤的种系和体细胞基因组景观
  • 批准号:
    10476420
  • 财政年份:
    2008
  • 资助金额:
    $ 13.32万
  • 项目类别:
Deciphering Germline and Somatic Genomic Landscape of Gliomas in Black and Hispanic Minority Groups
解读黑人和西班牙裔少数群体胶质瘤的种系和体细胞基因组景观
  • 批准号:
    10246334
  • 财政年份:
    2008
  • 资助金额:
    $ 13.32万
  • 项目类别:
Pathology and Biorepository Core (Core B)
病理学和生物样本库核心(核心 B)
  • 批准号:
    10476397
  • 财政年份:
    2008
  • 资助金额:
    $ 13.32万
  • 项目类别:

相似海外基金

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10490338
  • 财政年份:
    2021
  • 资助金额:
    $ 13.32万
  • 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10353104
  • 财政年份:
    2021
  • 资助金额:
    $ 13.32万
  • 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
  • 批准号:
    21K04320
  • 财政年份:
    2021
  • 资助金额:
    $ 13.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10688286
  • 财政年份:
    2021
  • 资助金额:
    $ 13.32万
  • 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
  • 批准号:
    20K17755
  • 财政年份:
    2020
  • 资助金额:
    $ 13.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10578649
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10295141
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10041708
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    9776149
  • 财政年份:
    2019
  • 资助金额:
    $ 13.32万
  • 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
  • 批准号:
    2063934
  • 财政年份:
    2018
  • 资助金额:
    $ 13.32万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了